Non-specific effects of standard measles vaccine at 4.5 and 9 months of age on childhood mortality: randomised controlled trial

P Aaby, CL Martins, ML Garly, C Balé, A Andersen… - Bmj, 2010 - bmj.com
Objective To examine in a randomised trial whether a 25% difference in mortality exists
between 4.5 months and 3 years of age for children given two standard doses of Edmonston …

Effects of food supplementation on cognitive function, cerebral blood flow, and nutritional status in young children at risk of undernutrition: randomized controlled trial

SB Roberts, MA Franceschini, RE Silver, SF Taylor… - bmj, 2020 - bmj.com
Objective To assess the effects of food supplementation on improving working memory and
additional measures including cerebral blood flow in children at risk of undernutrition …

A randomized trial of a standard dose of Edmonston-Zagreb measles vaccine given at 4.5 months of age: effect on total hospital admissions

CL Martins, CS Benn, A Andersen… - The Journal of …, 2014 - academic.oup.com
Observational studies and trials from low-income countries indicate that measles vaccine
has beneficial nonspecific effects, protecting against non–measles-related mortality. It is not …

Protective efficacy of standard Edmonston-Zagreb measles vaccination in infants aged 4.5 months: interim analysis of a randomised clinical trial

CL Martins, ML Garly, C Balé, A Rodrigues, H Ravn… - Bmj, 2008 - bmj.com
Objective To examine the protective efficacy of measles vaccination in infants in a low
income country before 9 months of age. Design Randomised clinical trial. Participants 1333 …

Thymus size at 6 months of age and subsequent child mortality

ML Garly, SL Trautner, C Marx, K Danebod… - The Journal of …, 2008 - Elsevier
OBJECTIVE: To examine determinants of thymus size at age 6 months and investigate
whether thymus size at this age is a determinant of subsequent mortality. STUDY DESIGN …

High-dose vitamin A with vaccination after 6 months of age: a randomized trial

AB Fisker, C Bale, A Rodrigues, I Balde… - …, 2014 - publications.aap.org
BACKGROUND: The World Health Organization recommends vitamin A supplementation
(VAS) at routine vaccination contacts after 6 months of age based on the assumption that it …

Co-administration of live measles and yellow fever vaccines and inactivated pentavalent vaccines is associated with increased mortality compared with measles and …

AB Fisker, H Ravn, A Rodrigues, MD Østergaard… - Vaccine, 2014 - Elsevier
Background Studies from low-income countries indicate that co-administration of inactivated
diphtheria–tetanus–pertussis (DTP) vaccine and live attenuated measles vaccine (MV) is …

Effect of an early dose of measles vaccine on morbidity between 18 weeks and 9 months of age: a randomized, controlled trial in Guinea-Bissau

VA Do, S Biering-Sørensen, AB Fisker… - The Journal of …, 2017 - academic.oup.com
Abstract Background Children in Guinea-Bissau receive measles vaccine (MV) at 9 months
of age, but studies have shown that an additional dose before 9 months of age might have …

[HTML][HTML] A pilot randomized controlled trial of a new supplementary food designed to enhance cognitive performance during prevention and treatment of malnutrition in …

SB Roberts, MA Franceschini, A Krauss, PY Lin… - Current developments in …, 2017 - Elsevier
Background Cognitive impairment associated with childhood malnutrition and stunting is
generally considered irreversible. Objective The aim was to test a new nutritional …

A randomized controlled trial of two ready-to-use supplementary foods demonstrates benefit of the higher dairy supplement for reduced wasting in mothers, and …

N Schlossman, C Brown, P Batra… - Food and nutrition …, 2017 - journals.sagepub.com
Background: There is no consensus over best approaches to reliably prevent malnutrition in
rural communities in low-income countries. Objective: We compared the effectiveness of 2 …